EMVISION ACHIEVES AUSTRALIAN STROKE ALLIANCE PROJECT MILESTONE TRIGGERING $600,000 NON-DILUTIVE GRANT PAYMENT
EMVision Medical Devices Ltd achieved a milestone in its Project Agreement with the Australian Stroke Alliance, triggering a $600,000 non-dilutive grant payment.
The milestone achieved involves the initiation of planning for "Ambulance Application – validation pilot studies."
EMVision is developing portable, non-invasive, affordable, and safe neuroimaging devices aimed at improving the diagnosis and treatment of stroke and other medical emergencies.
The company is based in Australia with offices in Sydney and Brisbane.
Forward-looking statements in the announcement highlight the speculative nature of investing in medical device development due to inherent risks such as the lengthy clinical trial process, regulatory approvals, and the competitive landscape.
EMVision emphasizes the need for professional investment advice due to the speculative nature of investments in medical device development companies.
This announcement is an AI summary of the company approved ASX announcement on 13/3/2024.